8.66
+0.7494(+9.48%)
Currency In USD
Address
409 Illinois Street
San Francisco, CA 94158
United States of America
Phone
415 978 1200
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
225
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Thane Wettig | Chief Executive Officer & Director | 1.13M | 1965 |
| David DeLucia | Senior VP & CFO | 597,537 | 1989 |
| John Alden | Corporate Secretary & General Counsel | 0 | N/A |
| Gaia Vasiliver-Shamis | Director of IR & Communications - LifeSci Advisors | 0 | N/A |
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.